Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amer Sports Inc (AS) vs BioNTech SE - ADR (BNTX) Price & Performance

Amer Sports IncTrade
BioNTech SE - ADRTrade

Price performance (Past 24H)

Key statistics

Amer Sports Inc vs BioNTech SE - ADR — how do they compare? Amer Sports Inc trades at $33.85 (market cap $21.04B), while BioNTech SE - ADR trades at $92.23 (market cap $23.31B). The key difference: Amer Sports Inc and BioNTech SE - ADR are close in size by market cap, and Amer Sports Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.

ASBNTX
Market Cap
$21.04B$23.31B
Sector
TechnologyHealth
52-Week High
$41.96$119.34
52-Week Low
$29.54$83.89
Enterprise Value
$21.36B$6.60B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amer Sports Inc

Amer Sports (AS) trades at $36.84, up 2.02% today, with a bullish technical signal from moving averages and strong analyst consensus. The company reported robust Q1 2026 results, beating EPS estimates with $0.38 versus $0.31 expected, and raised full-year guidance. Revenue grew 32% year-over-year to $1.95 billion, driven by strength in Arc'teryx and Salomon brands.

Outlook is positive given earnings momentum and raised 2026 guidance, but risks include high valuation (P/E 45.2) and dependence on premium brand sustainability. The consensus price target of $58.67 implies significant upside, supported by 12 buy ratings. Investors should monitor Q2 2026 earnings on August 18 for continued growth validation.

BioNTech SE - ADR

BioNTech (BNTX) trades at $93.67, up 2.72% today, with a bullish technical signal and strong analyst support. The stock faces fundamental challenges, including declining COVID-19 vaccine revenue and negative profitability, but holds a robust cash position of $16.78 billion. Recent news highlights leadership changes and pipeline advancements in oncology, with a consensus price target of $121.00 implying significant upside potential.

Outlook: Long-term growth hinges on oncology pipeline success, but near-term risks from vaccine demand volatility and net losses persist. Investment opportunity lies in discounted valuation relative to cash and pipeline assets, though execution risks and competitive pressures require careful monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amer Sports Inc

Amer Sports is a global group of iconic sports and outdoor brands, including Arc'teryx, Salomon, Wilson, and Atomic. It designs and manufactures high-quality equipment, apparel, and footwear for athletes worldwide.

Read more on AS

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX